Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial

PURPOSE: To compare the efficacy of intravenous (IV) iron (ferric derisomaltose) with oral iron (ferrous fumarate) in women 14–21 weeks pregnant with persistent iron deficiency (ferritin < 30 µg/L). METHODS: In a single-centre, open-label, randomised controlled trial at a Danish hospital, women w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Rebecka, Sommer, Veronika Markova, Pinborg, Anja, Krebs, Lone, Thomsen, Lars Lykke, Moos, Torben, Holm, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Maternal-Fetal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435604/
https://www.ncbi.nlm.nih.gov/pubmed/36107229
http://dx.doi.org/10.1007/s00404-022-06768-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435604/
https://www.ncbi.nlm.nih.gov/pubmed/36107229
http://dx.doi.org/10.1007/s00404-022-06768-x

Ejemplares similares